Karrin Weisenthal, MD, MHS
Assistant Professor, Emergency Medicine
Biography
Karri Weisenthal, M.D./M.H.S. is an Assistant Professor of Emergency Medicine at the Boston University Chobanian and Avedisian School of Medicine, the Associate Medical Director of Faster Paths to Treatment, Boston Medical Center’s low-barrier addiction bridge clinic, and the Medical Director for the integrated ED Addiction Consult Team. She graduated cum laude from the Yale School of Medicine and completed her residency training in Emergency Medicine and Addiction Medicine fellowship at Boston Medical Center.
Dr. Weisenthal is an active researcher in the fields of Emergency and Addiction Medicine, and she was awarded the SAEM Foundation/NIDA Mentor Facilitated Training Award to develop a curriculum on the incorporation of harm reduction into the care of patients who access emergency services. Her current research interests include improving initiation and access to medications for opioid use disorder in the emergency department (ED) with an equity lens, ensuring smooth transitions of care from the ED to outpatient settings, and integrating a harm reduction approach into the care of patients in the ED.
Websites
Education
- Yale University School of Medicine, MD
- Yale University School of Medicine, MHS
- Yale University, BA
Publications
- Published on 5/12/2024
Taylor JL, Gott J, Weisenthal K, Colicchio P, Dyer S, Komaromy MS. Post-Overdose Extended-Release Buprenorphine Initiation Facilitated by a Partnership Between Emergency Medical Services and an Outpatient Substance Use Disorder Observation Unit. Subst Use Addctn J. 2024 Oct; 45(4):771-776. PMID: 38736211.
Read at: PubMed - Published on 7/29/2022
Weisenthal K, Kimmel SD, Kehoe J, Larochelle MR, Walley AY, Taylor JL. Effect of police action on low-barrier substance use disorder service utilization. Harm Reduct J. 2022 Jul 29; 19(1):86. PMID: 35906660.
Read at: PubMed - Published on 5/13/2022
Zhao W, Jiang X, Weisenthal K, Ma J, Botticelli EM, Zhou Y, Hedley-Whyte ET, Wang B, Swearingen B, Soberman RJ, Klibanski A, Zhang X. High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary Tumors. Front Oncol. 2022; 12:875122. PMID: 35646715.
Read at: PubMed - Published on 6/9/2021
Moore CL, Bhargavan-Chatfield M, Shaw MM, Weisenthal K, Kalra MK. Radiation Dose Reduction in Kidney Stone CT: A Randomized, Facility-Based Intervention. J Am Coll Radiol. 2021 10; 18(10):1394-1404. PMID: 34115990.
Read at: PubMed - Published on 7/29/2018
Liu RB, Suwondo DN, Donroe JH, Encandela JA, Weisenthal KS, Moore CL. Point-of-Care Ultrasound: Does it Affect Scores on Standardized Assessment Tests Used Within the Preclinical Curriculum? J Ultrasound Med. 2019 Feb; 38(2):433-440. PMID: 30058124.
Read at: PubMed - Published on 9/1/2017
Levinsohn E, Weisenthal K, Wang P, Shahu A, Meizlish M, Robledo-Gil T, Duffy E, Fox S, Berk-Krauss J. No Time for Silence: An Urgent Need for Political Activism Among the Medical Community. Acad Med. 2017 09; 92(9):1231-1233. PMID: 28422815.
Read at: PubMed - Published on 8/31/2017
Weisenthal K, Karthik P, Shaw M, Sengupta D, Bhargavan-Chatfield M, Burleson J, Mustafa A, Kalra M, Moore C. Evaluation of Kidney Stones with Reduced-Radiation Dose CT: Progress from 2011-2012 to 2015-2016-Not There Yet. Radiology. 2018 02; 286(2):581-589. PMID: 28858562.
Read at: PubMed - Published on 6/23/2017
Daniels B, Schoenfeld E, Taylor A, Weisenthal K, Singh D, Moore CL. Predictors of Hospital Admission and Urological Intervention in Adult Emergency Department Patients with Computerized Tomography Confirmed Ureteral Stones. J Urol. 2017 12; 198(6):1359-1366. PMID: 28652122.
Read at: PubMed